
New injectables: technology meets biologic development
BySHL Group’s innovative technologies support highly viscous biologic formulations that are being developed to reduce the number of injections needed for patients. The...
Read more

A leading resource for the Pharmaceutical industry since 2002
SHL Group’s innovative technologies support highly viscous biologic formulations that are being developed to reduce the number of injections needed for patients. The...
Read more